drugset / Trial / NCT04061928

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ

NCT04061928

Phase 1/2 Unknown 45 enrolled Peking University
NaSingle-groupOpen-labelTreatment

Summary

This study aims to investigate the safety and efficacy of radiotherapy combined with Toripalimab (PD-1 inhibitor) in the treatment of locally advanced adenocarcinoma of the gastroesophageal junction.

Timeline

Start
2019-08-26
Primary completion
2022-08-25
Completion
2023-08-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Toripalimab Monoclonal antibody 240 mg Other